The FDA has approved once-daily oral Lynkuet for the treatment of moderate to severe hot flashes caused by menopause, ...

Preliminary results presented here showed use of a custom-tailored AI platform may be a feasible option to address ...

Academic medicine can be a rewarding path filled with opportunities for personal and professional growth, from teaching ...

The FDA approved revumenib for patients aged 1 year and older with relapsed or refractory acute myeloid leukemia with a ...

The FDA declined to approve SYD-101, a low-dose atropine formulation that would have been the first pharmaceutical treatment ...

The FDA approved belantamab mafodotin-blmf in combination with bortezomib and dexamethasone for the treatment of certain ...

Women who experience menopause at an earlier age and have a reduction in cardiac function are at increased risk for adverse ...

Topcon Healthcare launched IDHea Inc., a company focused on driving clinical research and oculomics to advance eye care, ...

Progesterone and dehydroepiandrosterone, but not estrogen and testosterone, may influence psoriasis pathogenesis, severity ...

I have been a psychiatrist for 20 years. I built Kaiser Permanente’s largest behavioral health integration program at its ...

Among individuals with MS, the risk of serious infection was higher and the time to the first serious infection was shorter ...

Patients staying in hospital rooms with multiple beds are at an increased risk — up to ninefold higher — for Staphylococcus aureus transmission compared with patients in single-bed rooms, according to ...